Sign in to continue:

Tuesday, April 7th, 2026

Gencor Industries, Inc. Files Form 8-K Reporting Company Information and SEC Compliance Details

Gencor Industries, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Orlando, FL – April 6, 2026 – Gencor Industries, Inc. (“Gencor” or “the Company”), a leading manufacturer of construction machinery and equipment, has released the results of its Annual Meeting of Stockholders held on April 3, 2026. The meeting included elections of directors, ratification of the independent auditor, and an advisory vote on executive compensation frequency. Below are the key highlights and detailed outcomes for shareholders and investors.

Key Points from the Annual Meeting

  • Director Elections: All director nominees were duly elected, ensuring continuity in the Company’s leadership and governance.
  • Ratification of Auditor: Shareholders overwhelmingly ratified Carr, Riggs & Ingram, L.L.C. as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2026.
  • Executive Compensation Advisory Vote Frequency: The shareholders approved holding an advisory vote on executive compensation every three years.

Details of Matters Voted On

1. Election of Directors

By holders of Common Stock:

  • John G. Coburn was elected with 5,451,083 votes for, 3,700,489 votes abstained/withheld, and 1,371,158 broker non-votes.

By holders of Class B Stock:

  • Marc G. Elliott – 2,318,857 votes for, 0 abstained/withheld, 0 broker non-votes
  • Thomas A. Vecchiolla – 2,318,857 votes for, 0 abstained/withheld, 0 broker non-votes
  • Walter A. Ketcham, Jr. – 2,318,857 votes for, 0 abstained/withheld, 0 broker non-votes

2. Ratification of Independent Registered Public Accounting Firm

Shareholders ratified the appointment of Carr, Riggs & Ingram, L.L.C. as the independent auditor for the year ending September 30, 2026, with the following vote breakdown:

  • Common Stock: 10,501,736 votes for, 16,730 against, 4,264 abstained/withheld, 0 broker non-votes
  • Class B Stock: 2,318,857 votes for, 0 against, 0 abstained/withheld, 0 broker non-votes

The overwhelming support for the auditor ratification is a positive affirmation of Gencor’s financial stewardship.

3. Advisory Vote on Executive Compensation Frequency

Shareholders approved a three-year frequency for the advisory vote on executive compensation:

  • Common Stock: 9,055,905 votes for 3 years, 76,509 against, 19,158 abstained, 1,371,158 broker non-votes
  • Class B Stock: 2,318,857 votes for 3 years, 0 against, 0 abstained, 0 broker non-votes

This signals shareholder confidence in the Company’s executive compensation policies and a preference for a longer review cycle.

Additional Shareholder Information

  • Total Shares Entitled to Vote: 12,338,845 shares of Common Stock and 2,318,857 shares of Class B Stock.
  • No other business was brought before the Annual Meeting.
  • All voting results indicate strong shareholder engagement and support for Company proposals and directors.

Potential Price-Sensitive Implications

  • The election of the full slate of directors and the ratification of the auditor suggest stability and continuity in management and oversight, which is generally viewed positively by investors.
  • The overwhelming support for a three-year cycle on executive compensation votes may signal to the market that shareholders are satisfied with the direction of executive pay and governance practices.
  • No contentious or surprise items were introduced during the meeting, reducing the risk of negative share price volatility in the near term.

Conclusion

Gencor Industries, Inc. continues to demonstrate strong governance, transparency, and alignment with shareholder interests. The results of the 2026 Annual Meeting reinforce the Company’s commitment to sound leadership, financial integrity, and responsible executive compensation practices. Barring unforeseen developments, the outcomes of this meeting are likely to be seen as neutral to modestly positive by the market.


Disclaimer: This article is based on the official SEC filing and is intended for informational purposes only. It does not constitute investment advice. Investors should conduct their own due diligence before making any investment decisions.

View GENCOR INDUSTRIES INC Historical chart here



Brandywine Realty Trust 10-K 2025: Real Estate Investment Trust Financials, Segments, and Equity Ventures

Brandywine Realty Trust 2025 10-K: Investor Analysis Bra...

Xtant Medical Holdings, Inc. Form 8-K SEC Filing – Company Information, Trading Symbol, and Contact Details

XTANT Medical Holdings, Inc. - Form 8-K Detailed Investor Re...

   Ad